Burning Rock Biotech (BNR) Accumulated Depreciation & Amortization (2020 - 2024)
Historic Accumulated Depreciation & Amortization for Burning Rock Biotech (BNR) over the last 5 years, with Q4 2024 value amounting to $7.2 million.
- Burning Rock Biotech's Accumulated Depreciation & Amortization fell 6194.05% to $7.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $7.2 million, marking a year-over-year decrease of 6194.05%. This contributed to the annual value of $7.2 million for FY2024, which is 6194.05% down from last year.
- According to the latest figures from Q4 2024, Burning Rock Biotech's Accumulated Depreciation & Amortization is $7.2 million, which was down 6194.05% from $18.8 million recorded in Q4 2023.
- Burning Rock Biotech's Accumulated Depreciation & Amortization's 5-year high stood at $18.8 million during Q4 2023, with a 5-year trough of $5.1 million in Q4 2020.
- In the last 5 years, Burning Rock Biotech's Accumulated Depreciation & Amortization had a median value of $8.2 million in 2021 and averaged $10.9 million.
- As far as peak fluctuations go, Burning Rock Biotech's Accumulated Depreciation & Amortization soared by 14002.13% in 2022, and later tumbled by 6194.05% in 2024.
- Quarter analysis of 5 years shows Burning Rock Biotech's Accumulated Depreciation & Amortization stood at $5.1 million in 2020, then surged by 46.84% to $7.5 million in 2021, then soared by 140.02% to $18.0 million in 2022, then grew by 4.43% to $18.8 million in 2023, then plummeted by 61.94% to $7.2 million in 2024.
- Its last three reported values are $7.2 million in Q4 2024, $18.8 million for Q4 2023, and $18.0 million during Q4 2022.